Download curriculum vitae - UT Southwestern

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
CURRICULUM VITAE
I General Biographic Information
A Personal
1. Name
Alan William Nugent, MBBS, FRACP, FSCAI.
2. Date of Birth
9th December 1967
Citizenship
Australian
3. Education
a. Undergraduate
Parade and Xavier College, Melbourne, Australia
b. Medical Education
The University of Melbourne MBBS 1991
c. Post graduate training
Internship:
Austin Hospital, Melbourne, Australia 1992.
Residency:
Royal Children’s Hospital, Melbourne, Australia 1993-1995.
Fellowship:
Royal Children’s Hospital Melbourne, Australia 1996-1999.
Children’s Hospital, Boston, MA 1999-2002
B. Academic Appointments
1. Current position:
Hospital Appointment
Children’s Medical Center, Dallas 2008-present.
Director of Cardiac Catheterization Laboratory.
Ancillary appointment
UT Southwestern Medical Center Hospitals:
St Paul University Hospital, Zale-Lipshy, Parkland Memorial Hospital.
Baylor University Medical Center
Academic Appointment Associate Professor Pediatrics, UT Southwestern Medical Center 2008Faculty Biomedical Engineering, UT Southwestern Graduate School of
Biomedical Science 20112. Previous position
Hospital Appointment Cardiology, Texas Children’s Hospital, Houston 2005-2008
Assistant in Cardiology, Children’s Hospital, Boston 2002-2005
Academic Appointment Assistant Professor Pediatrics, Baylor College Medicine 2005-2008
Instructor of Pediatrics, Harvard Medical School 2002-2005
Clinical Fellow in Pediatrics, Harvard Medical School 1999-2002
C. Specialized training
Interventional Catheterization, Cardiac Intensive Care Unit
D. Honors/Awards
Residential Scholarship Newman College, Melbourne, 1986.
Honors M.B;B.S. Melbourne University, 1991.
Neil Bromberger Prize in Orthopaedics, Austin Hospital Clinical
School, University of Melbourne, 1991.
Sigma-Cardiac Society of Australia and New Zealand Annual Scientific
Meetings Scholarship, 1998.
Winner AHA Scientific Sessions Poster Competition in Clinical
Science, 2004.
Best Doctors in America 2007-8, 2009-2010, 2011-2012.
Best Pediatric Specialists Dallas in 2011. D Magazine.
Nurses Week Participation Award, CMC 2011
E. Board Eligibility
Fellow Royal Australasian College of Physicians (FRACP)
Paediatrics and Child Health Division, 2002.
II Research Information
A. Research Support :
1.
a.Title
b. Funding
c. Investigator
d. Dates of funding
2.
a. Title
b. Funding
c. Investigator
d. Dates of funding
National Australian Childhood Cardiomyopathy Study
Project grant No 98001 Royal Children’s Hospital Research Foundation
Grant G98M0159 National Heart Foundation of Australia, Australia
and New Zealand Children’s Heart Research Center.
Co- Primary Investigator
1997-1999
Safety and Efficacy of the Cutting Balloon to Treat Resistant
Pulmonary Artery Stenosis. IDE#G030033
Boston Scientific
Primary Investigator at Baylor College of Medicine.
2007-8
b. Funding
c. Investigator
d. Dates of funding
The STARFlex Septal Occluder in Atrial Septal Defect – Long Term
Status of patients following closure of ASD with the STARFlex Septal
Occlusion System in IDE#G-960098
NMT medical
Primary Investigator at Baylor College of Medicine
2007-8
4.
a. Title
b. Funding
c. Investigator
d. Dates of funding
Coarctation for Aorta Stent Trial (COAST), IDE#G060057
Numed
Co-Investigator Baylor College of Medicine/UT Southwestern
2007-2010
5.
a. Title
b. Funding
c. Investigator
d. Dates of funding
Biodegradable stents for congenital heart disease
Department Pediatrics University of Texas Southwestern
Primary Investigator
2008-
6.
a. Title
Closure of Ventricular Septal defects with the Amplatzer VSD
Occluder Post Approval Study (VPA), IDE#P040040,
ClinicalTrials.gov identifier NCT00647387
AGA Medical
Co-Investigator University of Texas Southwestern
2009-
3.
a. Title
b. Funding
c. Investigator
d. Dates of funding
7.
a. Title
b. Funding
c. Investigator
d. Dates of funding
8.
a. Title
b. Funding
c. Investigator
d. Dates of funding
Melody Transcatheter Pulmonary Valve Post Approval Study,
HDE#H080002
Medtronic
Co-Investigator University of Texas Southwestern
2010Covered Cheatham-Platinum Stent for Prevention or Treatment of
Aortic Wall Injuries Associated with Aortic Coarctation (COAST II),
IDE#G060057/S099
Numed
Co-Investigator University of Texas Southwestern
2010-
B. National Scientific Participation:
1. Journal Review
Circulation
Circulation: Cardiovascular Interventions
Texas Heart Institute Journal.
Congenital Heart Disease
Catheterization and Cardiovascular Interventions
2. Professional Societies
Royal Australasian College of Physicians
Fellowship Society for Cardiovascular Angiography and Interventions
American Heart Association
American College of Cardiology
Dallas County Medical Society
Texas Medical Association
Pediatric Society of Greater Dallas
3. Invited Lectures
1) Children’s Hospital Boston 4th Course on Frontiers in Congenital Heart Disease, May 2003.
Transcatheter management of Pulmonary Vein Stenosis.
2) Section of Cardiology, Department of Pediatrics, Texas Children’s Hospital, February 2005.
Pulmonary Vein Stenosis. Interventional History and Future Directions.
3) Department of Pediatrics, University of Chicago, Comer Children’s Hospital, June 2007.
Interventional Cardiology for Structural Heart Disease. Personal Lessons.
4) Adolph Basser Cardiac Institute, The Children’s Hospital at Westmead, Sydney December 2007.
Interventional Catheterization: Future Directions.
5) University of Texas Southwestern, Pediatric Department Faculty Research Conference 2010.
Biodegradable stents in congenital heart disease.
6) University of Texas Southwestern, Pediatric Department Grand Rounds January 12, 2011
Percutaneous Pulmonary Valve Replacement
7) Faculty American College of Cardiology Annual Scientific Sessions, Chicago March 2012
Pulmonary Vein Stenosis: What are the Realistic Expectations?
Transcatheter Pulmonary Vein Interventions: Do They Help? How and When?
8) Faculty Society for Cardiovascular Angiography & Interventions, Las Vegas May 2012.
4. Miscellaneous
FDA-SCAI-Industry Bioabsorbable Products Task Force 2010-present
C. Research Interests.
Biodegradable stents for congenital heart disease
Fetal cardiac intervention.
D. Bibliography
1.
Published papers
1) Nugent A, Menahem S, Goh TH, Butt W. Device closure of an atrial septal defect following
successful balloon valvuloplasty in a neonate with critical pulmonary valve stenosis and persistent
cyanosis. Pediat Cardiol 2000; 21:170-71
2) Nugent AW, Davis AM, Kleinert S, Wilkinson JL, Weintraub RG. Electrocardiographic predictors
of myocardial histology in paediatric patients with dilated cardiomyopathy. J Heart Lung
Transplant. 2001; 20:1152-1157.
3) Nugent A, Daubeney P, Chondros P, Carlin J, Cheung M, Wilkinson L, Davis A,, Kahler S, Chow
C, Wilkinson J, Weintraub R for the National Australian Childhood Cardiomyopathy Study. The
Epidemiology of Childhood Cardiomyopathy in Australia. N Engl J Med. 2003; 348:1639-46.
4) Shaw JA, Dewire E, Nugent A, Eisenhauer AC. Use of Suture-Mediated Vascular Closure
Devices for the Management of Femoral Vein Access After Transcatheter Procedures. Cath
Cardiovasc Interv 2004; 63:439-443.
5) Frye RE, Newburger JW, Nugent A, Sahin M. Focal Seizure and Cerebral Contrast Retention
After Cardiac Catheterization. Pediatr Neurol 2005; 32:213-216.
6) Nugent A, Daubeney P, Chondros P, Carlin J, Colan S, Cheung M, Davis A, Weintraub R on
behalf of the National Australian Childhood Cardiomyopathy Study. Clinical Features and
Outcomes of Childhood Hypertrophic Cardiomyopathy: Results from a National Population-Based
Study. Circulation 2005; 112:1332-1338.
7) Riedlinger WFJ, Juraszek AL, Jenkins KJ, Nugent AW, Balasubramanian S, Kieren MW, Collins
T. Pulmonary Vein Stenosis: Expression of Receptor Tyrosine Kinases by Lesional Cells.
Cardiovasc Pathol 2006; 15:91-99.
8) Peng LF, McElhinney DB, Nugent AW, Powell AJ, Marshall AC, Bacha EA, Lock JE.
Endovascular Stenting of Obstructed Right Ventricle-to-Pulmonary Artery Conduits: a 15-Year
Experience. Circulation 2006; 113:2598-2605.
9) Nugent A, Britt A, Gavreau K, Piercey G, Lock J, Jenkins K. Device Closure Rates of Simple
Atrial Septal Defects Optimized by STARFlex Device. J Am Coll Cardiol 2006; 48:538-44.
10) Daubeney P, Nugent A, Chondros P, Carlin J, Colan S, Cheung M, Davis A, Chow C, Weintraub
R. Clinical Features and Outcomes of Childhood Dilated Cardiomyopathy: Results from a
National Population-Based Study. Circulation 2006; 114:2671-2678
11) Weintraub RG, Nugent AW, Daubeney PEF. Pediatric Cardiomyopathy: The Australian
Experience. Progress in Pediatric Cardiology 2007;23:17-24.
12) Slesnick TC, Nugent AW, Fraser CD, Cannon BC. Incomplete Endothelialization and Late
Development of Acute Bacterial Endocarditis after Implantation of an Amplatzer Septal Occluder
Device. Circulation 2008;117:e326-327.
13) Breinholt JP, Nugent AW, Law MA, Justino H, Mullins CE, Ing FF. Stent fractures in Congenital
Heart Disease. Catheter Cardiovasc Interv 2008;72:977-982
14) Law MA, Josey J, Ing FF, Justino H, Mullins CE, Nugent A. Long term follow-up of the
STARFlex device for closure of Secundum ASD. Catheter Cardiovasc Interv 2009;73:190-195.
15) Stapleton GE, Hamzeh, R, Mullins CE, Zellers TM, Justino H, Nugent A, Nihill MR, Grifka RG,
Ing FF. Simultaneous Stent Implantation to Treat Bifurcation Stenosis in the Pulmonary Arteries:
Initial Results and Long Term Follow-up. Catheter Cardiovasc Interv 2009;73:557-63.
16) Ruiz CE, Cohen HA, Nugent AW, Kramer P. Long-term follow-up of the STARFlex device for
closure of secundum atrial septal defect. Catheter Cardiovasc Interv 2009;74:525-526.
17) Law MA, Shamzsad P, Nugent AW, Justino H, Breinholt JP, Mullins CE, Ing FF. Pulmonary
Artery Stents : Long term follow-up. Catheter Cardiovasc Interv 2010;75:757-64.
18) Peng LF, Lock JE, Nugent AW, Jenkins KJ, McElhinney DB. Comparison of conventional and
cutting balloon angioplasty for congenital and postoperative pulmonary vein stenosis in infants and
young children. Catheter Cardiovasc Interv 2010;75:1084-1090.
19) Dimas VV, Takao C, Ing FF, Mattamal R, Nugent AW, Grifka RG, Mullins CE, Justino H.
Outcomes of transcatheter occlusion of patent ductus arteriosus in infants weighing 6 kilograms or
less. J Am Coll Cardiol Intv 2010;3:1295-9.
20) Weintraub RG, Nugent AW, Davis A, King I, Barucha T, Daubeney PEF. Presentation,
echocardiographic findings and long term outcomes in children with familial dilated
cardiomyopathy. Prog Pediatr Cardiol 2011;31: 119-122.
21) Bergersen L, Gauvreau K, Justino H, Nugent A, Rome J, Kreutzer J, Rhodes J, Nykanen D, Zahn
E, Latson L, Moore P, Lock JE, Jenkins KJ. Randomized Trial of Cutting Balloon Compared with
High-Pressure Angioplasty for the Treatment of Resistant Pulmonary Artery Stenosis. Circulation
2011;124:2388-2396.
22) Balasubramanian S, Marshall AC, Gauvreau K, Peng LF, Nugent AW, Lock JE, McElhinney DB.
Outcomes after Stent Implantation for the Treatment of Congenital and Postoperative Pulmonary
Vein Stenosis in Children. Circ Cardiovasc Interv. Published online January 17, 2002.
23) Meadows J, Forbess J, Michel-Behnke I, Sigler M, Nugent AW. Congenital Heart Disease –
Recent Innovations and Discoveries. Catheter-based Interventions for Congenital Heart Disease.
Journal of Clinical and Experimental Cardiology. In Press.
In submission:
1) Nugent A, Meadows J, Love B, Perry S, Lock J. Covered Stents in Congenital Heart Disease:
Shortcomings with Self-Manufactured Stents.
2) Powers S, Petit CJ, Justino H, Mullins CE, Ing F, Nugent A. Excellent outcomes more than 10
years after percutaneous pulmonary valvuloplasty.
3) Law MA, Nugent AW, Justino H, Mullins CE, Ing FF. The outcome of branch pulmonary artery
stenoses following surgical alteration of previously implanted stents.
4) Daubeney PEF, Nugent A, Chondros P, Bharucha T, Cheung M, Chow CW, King I, Davis AM,
Colan S, Ramsay J, Weintraub RG. Clinical features and long term outcomes of left ventricular
noncompaction in childhood: Results from a national population based study of childhood
cardiomyopathy.
5) Bharucha T, Lee K, Daubeney PEF, Nugent AW, Turner C, Sholler G, Robertson T, Justo R,
Ramsay J, Carlin JB, Colan SD, Davis AM, King I, Weintraub RG. Sudden Death in Children with
Cardiomyopathy: Observations from a National Population-Based Study of Childhood
Cardiomyopathy.
6) Alexander PMA, Daubeney PEF, Nugent AW, Lee KJ, Turner C, Colan S, Robertson T, Davis
AM, Ramsay J, , Justo R, Sholler GF, King I, Weintraub RG. Long term outcomes of Dilated
Cardiomyopathy Presenting during childhood: Results from a National Population-Based Study of
Childhood Cardiomyopathy
In preparation:
1) DeSena H, Veeram Reddy SR, Wang J, Welch T, Forbess J, Nugent A. Morphology of Inter Atrial
Defects Created by Different Inteventional Techniques in an Animal Model.
2) Nugent A, Juraszek A, Ikemba C, Kowal R, Magee K. Fetal Bench Model of Antegrade Aortic
Valve Dilation.
.
3) Nugent A, Dyer A, Eapen R, Ikemba C, Kowal R, Talcott M, Magee K. Magnetically Assisted
Fetal Cardiac Inventions: Antegrade Aortic Valve Dilation in a Fetal Lamb.
4) Nugent A, Dyer A, Eapen R, Ikemba C, Kowal R, Talcott M, Magee K. Magnetically Assisted
Fetal Cardiac Inventions: Pulmonary Valve Dilation in a Fetal Lamb.
5) Dyer A, Scott W, Kowal R, Eapen R, Ikemba C, Talcott M, Magee K, Nugent A. Magnetically
Assisted Fetal Cardiac Pacing of the Atria and Ventricles in a Fetal Lamb Model.
6) Barker G, Forbess J, Guleserian K, Nugent A. Percutaneous Left Atrial Decompression Followed
by Pulmonary Artery Bands as Bridge to Norwood in Hypoplastic Left Heart Syndrome with Intact
Atrial Septum.
2. Book chapters:
1) Nugent A, Laussen PC. Diagnostic and Therapeutic Cardiac Catheterization. In Pediatric Critical
Care 3rd Edition. Fuhrman BP and Zimmerman JJ (Eds). Mosby Inc, St Louis, MO 2006. Pg 285297.
2) Jefferies JL, Nihill MR, Nugent AW. Congenital heart disease. In: 900 Questions: An
Interventional Cardiology Board Review. 1st ed. Mukherjee D, Cho L, Moliterno D (Eds).
Lippincott-Williams and Wilkins. Philadephia, PA 2007. Pg 244-253.
3) Nugent A. Catheter intervention. In Pediatric Heart Disease: A Practical Guide. Editors Daubeney,
Webber, Niwa and Gatzoulis. In Press.
3. Non peer reviewed publications:
1) Nugent A Noninvasive perinatal cardiology – Part II. Pediatric Society of Greater Dallas, Fourth
Quarter Newsletter, November 2008.
4. Recent Abstracts
1) American College Cardiology 53rd Annual Scientific Session, Atlanta March 2004.
a. Sena L, Nugent A, Tan P, Kieran M, Colin A, Taylor G, Jenkins K. Diffuse pulmonary
pathology rapidly progressive pulmonary vein stenosis by computed tomography.
b. Weintraub RG, Chondros P, Nugent A, Carlin J, Daubeney PEF. Thromboembolic events
among children with cardiomyopathy: Results from the National Australian Childhood
Cardiomyopathy Study.
2) American Academy of Pediatrics, San Francisco October 2004.
a. Nugent A, Britt A, Gauvreau K, Piercey G, Lock JE, Jenkins KJ. Comparable closure
rates of simple atrial septal defects by STARFlex device to surgery.
3) American Heart Association Scientific Sessions, New Orleans November 2004.
a. Nugent AW, Sutton NJ, Dillis S, Jenkins K. Direct tissue removal via catheterization is an
effective palliation for recurrent pulmonary vein stenosis.
4) Eastern and National SPR annual meeting, March and May 2005.
a. Bergersen L, Nugent A, Keane J, Gauvreau K, Lock J, Jenkins K. Adverse event rates for
pediatric cardiac catheterization procedures: identification of high risk populations.
b. Bergersen L, Nugent A, Keane J, Gauvreau K, Lock J, Jenkins K. Adverse event rates for
pediatric cardiac catheterization procedures: development of risk adjustment model.
5) American College Cardiology 55th Annual Scientific Session, Atlanta GA March 2006
a. Peng LF, McElhinney DB, Nugent AW, Powell AJ, Marshall AC, Bacha EA, Lock JE.
Bare stenting of obstructed right ventricle to pulmonary artery conduits. A fifteen year
experience.
6) Society for Cardiovascular Angiography and Intervention, May 2007
a. Justino H, Nugent AW, Ing F, Mullins CE, Davenport JJ, O’Brien R. Neonatal superior
vena cava syndrome: Results of Transcatheter therapy.
b. Law MA, Nugent AW, Justino H, Mullins CE, Ing FF. The outcome of branch pulmonary
artery stenoses following surgical alteration of previously implanted stents.
c.
d.
Stapleton GE, Zellers TM, Mullins CE, Justino H, Nugent AW, Nihill MR, Grifka RG,
Ing FF. Simultaneous implantation of 2 stents to treat bifurcation stenoses in pulmonary
arteries: early, intermediate and long term results.
Davenport JJ, Mullins CE, Justino H, Grifka RG, Nugent A, Ing F. Mega LD and Max
LD stents: A new generation of open cell design for use in Congenital Heart Disease.
7) American Society of Echocardiography Scientific Sessions, June 2007
a. Slesnick TS, Nugent A, Fraser CD, Cannon BC. Incomplete endothelialization and late
development of acute bacterial endocarditis after implantation of an Amplatzer atrial
septal occluder device. Case Competition presentation.
8) Pediatric Interventional Cardiology Symposium, July 2007
a. Breinholt J, Mullins C, Nihill M, Justino H, Nugent A, Ing F. Stent fractures in congenital
heart disease.
9) SCAI/I2 summit, Chicago March 2008
a. Justino H, Nugent A, Petit C, Diez J, Ing F. Cutting Balloons in the Management of
Pediatric Systemic Venous Stenosis.
b. Law MA, Shamzsad P, Nugent A, Breinholt JP, Justino H, Petit CJ, Mullins CE, Ing FF.
Pulmonary Artery Stents – Long term follow-up.
10) American College Cardiology 57th Annual Scientific Session, Chicago March 2008.
a. Daubeney PEF, Nugent A, Chondros P, Chueng M, Chow CW, Sjoberg G, Davis A, King
I, Weintraub RG. Clinical features and long term outcomes for children with left
ventricular non-compaction: Results from a population-based study of childhood
cardiomyopathy. Best Poster Award Competition.
11) American Heart Association Scientific Sessions, New Orleans November 2008.
a. Bharucha T, Davis AM, Turner C, Justo R, Robertson T, Ramsay J, Daubeney PE,
Nugent AW, King I, Weintraub RG. Sudden death in children with cardiomyopathy: long
term follow-up from a national population based study of childhood cardiomyopathy.
Alexander S. Nadas Memorial Lecture and Outstanding Research Award in Pediatric
Cardiology.
12) I2 Summit, American College Cardiology 58th Annual Scientific Session, Orlando March 2009
a. Lisa Bergersen, Kimberlee Gauvreau, Jonathan Rome, Jackie Kreutzer, David Nykanen,
Evan Zahn, Larry Latson, Jonathan Rhodes, Alan Nugent, Henri Justino, Phillip Moore,
James Lock, Kathy Jenkins. The safety and efficacy of cutting balloon versus high
pressure balloon therapy for the treatment of resistant pulmonary artery stenosis: a multicenter randomized trial.
b. Christopher J. Petit, Frank F. Ing, Raphael Mattamal, Alan W. Nugent, Henri Justino.
Balloon aortic valvuloplasty in neonates: a single center 10-year experience.
13) Society for Cardiovascular Angiography & Interventions Las Vegas May 2009.
a. Frank Ing, Henri Justino, Alan Nugent, Christopher Petit. Stenting The Ductus Arteriosus
For Pulmonary Blood Flow: Focus On Duration Of Palliation And Reintervention.
14) American College Cardiology 59th Annual Scientific Session, Atlanta March 2010
a. Alexander PM, Lee K, Daubeney P, Turner C, Robertson T, Nugent A, Davis A, Ramsay
J, Justo R, Bharucha T, King I, Weintraub R. Long term outcomes of Dilated
Cardiomyopathy presenting during childhood.: results from a national population-based
study of childhood cardiomyopathy.
b. Alexander PM, Lee K, Nugent A, Turner C, Robertson T, Daubeney P, Davis A, Ramsay
J, Justo R, Bharucha T, King I, Weintraub R. Long term outcomes of Hypertrophic
Cardiomyopathy presenting during childhood.: results from a national population-based
study of childhood cardiomyopathy
15) American Heart Association Scientific Sessions, Orlando, November 2011
a. Reddy SV, Welch T, Wang J, Bernstein F, Richardson J, Eberhart RC, Forbess JM,
Nugent AW. A Novel Biodegradable Stent Design Applicable for Pediatric Use in
Congenital Heart Disease: Bench Testing and Initial Results in a Rabbit Model.
16) UTSW Medical Center, UT Dallas, UT Arlington Sixth Annual Metroplex Day, February 2012
a. Welch TR, Veeram Reddy S, Wang J, Eberhart R, Bernstein F, Richardson J, Forbess J,
Nugent A. Mechanical Properties and Preliminary In-Vivo Results of a Novel
Biodegradable Stent Design for Use in Congenital Heart Disease.
17) American College Cardiology 59th Annual Scientific Session, Chicago March 2012.
a. Daubeney PEF, Alexander P, Nugent A, Lee K, Colan S, Davis A, King I, Weintraub R.
Survival and Reverse Cardiac Remodelling in Childhood Dilated Cardiomyopathy
(DCM): Results from a Long-Term National Population-Based Study.
18) AATS Annual Meeting.
a. Guleserian K, Sharma MS, Barker GM, Macaluso J, Nugent AW, Forbess JM. Bilateral
Pulmonary Artery Banding for Resuscitation in High-Risk Single Ventricle Neonates and
Infants: Single Center Experience.
19) Society for Cardiovascular Angiography & Interventions Las Vegas May 2012.
a. Nugent A, Dyer A, Eapen R, Ikemba C, Kowal R, Talcott M, Magee K. Magnetically
assisted fetal cardiac inventions: antegrade aortic valve dilation in a fetal lamb.
b. De Senna H, Veeram Reddy SR, Wang J, Welch T, Forbess J, Nugent A. Morphology of
Inter Atrial Defects Created by Different Interventional Techniques in an Animal Model.
III. Teaching Information
1996
1996
1996
1998/9
2003/4
2003
2005
2006
2007
2008
2009-12
2011-12
Mayfield Education Centre Lecturer (Technician course)
Trinity College (Melbourne University) paediatric tutor
Assistant FRACP clinical examination (paediatrics)
Paediatric Cardiology tutor Mmed, University of Melbourne
Harvard Medical School: Lecturer, Human Systems Module I:
Pediatric Cardiology, HMS yr 2
CHB Residents Cardiology tutorial
CHB Cardiology fellows lecture series
TCH Cardiology fellows lecture series
Cardiology and Critical Care fellows lecture series
TCH Cardiology fellows Catheterization lectures
UTSW/CMC Cardiology fellows lectures
UTSW/CMC Cardiology fellows lectures
CMC CVICU Lecture series
UTSW/CMC Critical Care lecture series
Simulation CVICU, catheterization laboratory
IV. Medical & Service Information
A. Patient Care Responsibilities
Cardiac Intensive Care Unit
Cardiology Inpatient Ward
Cardiology Outpatient Clinic
B. Clinical Laboratory Responsibilities
Cardiac Catheterization
C. Administration
President Resident Medical Officers, RCH.
Chief Cardiology Fellow, Children’s Hospital, Boston.
Cardiac Catheterization Laboratory Advisory Committee,
Texas Children’s Hospital.
Director of Cardiac Catheterization Laboratory, CMC.
Training Program Director Interventional Cardiology, CMC
Heart Center Leadership Advisory Board, CMC
Infection Control Committee, CMC.
Search Committee Chief Division of Critical Care
Director Fetal Cardiac Intervention, CMC
1997
2001-2
2005-8
2008-present
2009-present
2010-present
2011-present
2011-present
2012-
D. Licensure and Certification
1997
1992-1999
1999-2002
2002-present
2005-present
E. Patents
US Patent
European
Educational Commission for Foreign Medical Graduates
Full License Medical Board of Victoria, Australia.
Limited License Massachusetts Board of Registration in
Medicine
Full License Massachusetts Board of Registration in Medicine
(2006 onwards - inactive)
Full License Texas State Board Medical Examiners
2012
Patent No. 8,092,524 (1/10/2012, filed 12/3/2008).
Transcatheter delivery of a replacement heart valve.
Nugent A, Lock J. Continuation of below.
2008
Patent No. 7, 470, 285 (12/30/2008, filed 2/7/2005).
Transcatheter delivery of a replacement heart valve.
Nugent A, Lock J.
2007
Patent number 05722779.5-2310-US2005003749.
Transcatheter delivery of a replacement heart valve.
Related documents